Lv72
4980 积分 2023-06-12 加入
EFTX-G12V: a novel KRASG12V-selective RNAi therapeutic
20小时前
已完结
A first-in-class EGFR-directed KRAS G12V selective inhibitor
21小时前
已完结
Antibody-oligonucleotide conjugates in cancer therapy: Potential and Promise
9天前
已完结
RNA stability enhancers for durable base-modified mRNA therapeutics
28天前
已完结
Development of a modified RNA circularization system to improve circRNA-based protein expression in mammalian cells
29天前
已完结
Lipid nanoparticle delivery of circle RNA vaccine induces potent immune responses
29天前
已完结
IRES–cargo interplay structurally modulates circular RNA translation
29天前
已完结
Internal cap-initiated translation for efficient protein production from circular mRNA
1个月前
已完结
In vivo site-specific engineering to reprogram T cells
1个月前
已完结
Evaluation of RNAi therapeutics VIR-2218 and ALN-HBV for chronic hepatitis B: Results from randomized clinical trials
1个月前
已完结
皖公网安备34019202002308
